Yersinia enterocolitica serotype O:3 is arthritogenic for mice
Related Experiment Video
Updated: Oct 13, 2026
Oral Transmission of Listeria monocytogenes in Mice via Ingestion of Contaminated Food
Published on: May 6, 2013
J R de los Toyos1, J Vázquez, A Sampedro
1Area de Microbiologia, Facultad de Medicina, Universidad de Oviedo, Spain.
Abstract:
It is shown, for the first time, that Yersinia enterocolitica serotype O:3 is experimentally arthritogenic. Moreover, it is arthritogenic for the mouse, an optimal model for human yersiniosis. This arthritis can be induced by the oral route, the most common route in man. The pattern of joint disease closely parallels that of human reactive arthritis associated with this pathogen.
Insights
Yersinia enterocolitica serotype O:3 causes experimental arthritis in mice, mimicking human reactive arthritis. This finding is crucial as the infection route is oral, common in humans.
Area of Science:
- Microbiology
- Immunology
- Rheumatology
Background:
- Yersinia enterocolitica is a significant human pathogen.
- Reactive arthritis is a debilitating joint disease.
- The mouse model is critical for studying human diseases.
Purpose of the Study:
- To determine if Yersinia enterocolitica serotype O:3 is arthritogenic.
- To establish a mouse model for Yersinia-induced arthritis.
- To compare experimentally induced arthritis with human reactive arthritis.
Main Methods:
- Experimental induction of arthritis in mice using Yersinia enterocolitica O:3.
- Oral administration of the pathogen to mimic human exposure.
- Clinical and pathological assessment of joint disease.
Main Results:
- Yersinia enterocolitica serotype O:3 was experimentally shown to be arthritogenic.
- The mouse model accurately reflects human yersiniosis and associated arthritis.
- Arthritis induction via the oral route was successful.
Conclusions:
- Yersinia enterocolitica O:3 is a novel causative agent of experimental arthritis.
- The mouse model provides valuable insights into human reactive arthritis pathogenesis.
- Understanding this model aids in developing therapeutic strategies for yersiniosis.
